ProtaGene Appoints Matthias Bucerius as Chief Executive Officer
PRIVATEOct 28, 2026
New to company · from Merck KGaA“Former Merck KGaA CDMO Leader Matthias Bucerius as Chief Executive Officer”
Position
Chief Executive Officer
Company
ProtaGene
Matthias Bucerius, PhD
ManufacturingBiotechnology
Description
ProtaGene has announced the appointment of Matthias Bucerius, PhD, as Chief Executive Officer, effective immediately. Bucerius brings extensive experience from his previous role at Merck KGaA, where he led multiple drug substance sites.
Who to call at ProtaGene, and when
A new leader at ProtaGene brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day ProtaGene raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at ProtaGene, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ProtaGene. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
ProtaGene
About
ProtaGene is a protein characterisation specialist that focuses on advanced protein characterisation and drug product characterisation. They provide services to support drug development and enhance product quality. ProtaGene's expertise lies in the biopharmaceutical industry.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ProtaGene changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
